close 74% of retail investor accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

SIE

209

+4.73%↑

AIR.FR

163.22

+2.91%↑

ENR.DE

147.45

+7.08%↑

RHM

1,463.5

+0.21%↑

HO

237.7

+1.02%↑

SIE

209

+4.73%↑

AIR.FR

163.22

+2.91%↑

ENR.DE

147.45

+7.08%↑

RHM

1,463.5

+0.21%↑

HO

237.7

+1.02%↑

SIE

209

+4.73%↑

AIR.FR

163.22

+2.91%↑

ENR.DE

147.45

+7.08%↑

RHM

1,463.5

+0.21%↑

HO

237.7

+1.02%↑

SIE

209

+4.73%↑

AIR.FR

163.22

+2.91%↑

ENR.DE

147.45

+7.08%↑

RHM

1,463.5

+0.21%↑

HO

237.7

+1.02%↑

SIE

209

+4.73%↑

AIR.FR

163.22

+2.91%↑

ENR.DE

147.45

+7.08%↑

RHM

1,463.5

+0.21%↑

HO

237.7

+1.02%↑

Home・Stock List・HOCHTIEF AG
Search

HOCHTIEF AG

Open

SectorIndustrials

391.8 5.15

Neutral

Price update 24 Mar 2026, 09:12 UTC

BuySell

Overview

Share price change

24h

Current

Min

365.6

Max

410.6

Key metrics

By Trading Economics

Income

72M

247M

Sales

388M

10B

EPS

4.09

Dividend yield

3.17

Profit margin

2.436

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-16.44% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.17%

2.23%

Next Earnings

11 May 2026

Market Stats

By TradingEconomics

Market Cap

4.7B

Previous open

386.65

Previous close

391.8

News Sentiment

By Acuity

50%

50%

177 / 406 Industrials

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

159.1 / 167.5 Support & Resistance

HOCHTIEF AG Chart

Past performance is not a reliable indicator of future results.

Related News

23 Mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

DJ

Read

23 Mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

DJ

Read

23 Mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

DJ

Read

23 Mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

23 Mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

DJ

Read

23 Mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

DJ

Read

23 Mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

DJ

Read

23 Mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

DJ

Read

23 Mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

DJ

Read

23 Mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

DJ

Read

23 Mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

DJ

Read

23 Mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

DJ

Read

23 Mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

DJ

Read

23 Mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

DJ

Read

23 Mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

DJ

Read

23 Mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

DJ

Read

23 Mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

DJ

Read

23 Mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

DJ

Read

23 Mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

DJ

Read

23 Mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

DJ

Read

23 Mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

DJ

Read

23 Mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

23 Mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

DJ

Read

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

DJ

Read

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

DJ

Read

23 Mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

DJ

Read

23 Mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

DJ

Read

23 Mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

23 Mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

23 Mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

HOCHTIEF AG Forecast

Price Target

By TipRanks

-16.44% downside

12 Months Forecast

Average 329.57 EUR  -16.44%

High 387 EUR

Low 296 EUR

Based on 4 Wall Street analysts offering 12 month price targets forHOCHTIEF AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

4 ratings

0

Buy

3

Hold

1

Sell

Based on 4 analysts giving stock ratings to HOCHTIEF AG - Dist in the past 3 months.

Technical Score

By Trading Central

159.1 / 167.5Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Bullish Evidence

All events are bullish.

Sentiment

By Acuity

177 / 406 Industrials

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

Operating profit

$

About HOCHTIEF AG

There is no Profile data available for HOT.BE.

Other stocks from the sector

SIE

Siemens AG

209

↑ +4.73%

AIR.FR

Airbus SE

163.22

↑ +2.91%

ENR.DE

Siemens Energy AG

147.45

↑ +7.08%

RHM

Rheinmetall AG

1,463.5

↑ +0.21%

HO

Thales SA.

237.7

↑ +1.02%
help-icon Live chat